| Literature DB >> 25126946 |
Haiqing Wang1, Jian Yang1, Jiayin Yang1, Li Jiang1, Tianfu Wen1, Wentao Wang1, Mingqing Xu1, Bo Li1, Lunan Yan1.
Abstract
OBJECTIVE ANDEntities:
Mesh:
Year: 2014 PMID: 25126946 PMCID: PMC4134261 DOI: 10.1371/journal.pone.0105114
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Preoperative Characteristics of the patients.
| Preoperative Characteristics | All patients | No Complications– | Grades III–V | P Value |
| (n = 1543) | Grade II(n = 1418) | (n = 125) | ||
| Male, (%) | 1294(83.9%) | 1183 (83.4%) | 111 (88.8%) | 0.118 |
| Age≥65 years, (%) | 207(13.4%) | 186(13.1%) | 21(16.8%) | 0.247 |
| BMI | 22.5(20.9–24.7) | 22.6(20.9–24.7) | 22.5(20.9–24.8) | 0.620 |
| HBsAg(+) | 1250(81%) | 1150 (81.1%) | 100 (80%) | 0.764 |
| HBeAg(+) | 246 (15.9%) | 219(15.4%) | 27 (21.6%) | 0.072 |
| HBV DNA(+) | 483(31.3%) | 440 (31.1%) | 43 (34.4%) | 0.436 |
| AST | 40(28–63) | 39(28–62) | 46(33–71) | 0.005 |
| ALT | 39(28–59) | 39(28–58) | 43(30.5–61.5) | 0.104 |
| Tumor size(cm), median(IQR) | 5(4–8) | 5(3.25–8) | 5.75(4–8) | 0.185 |
| Tumor Number, (%) | 0.241 | |||
| Solitary | 1311(85.0%) | 1200(84.6%) | 111(88.8%) | |
| Multiple | 232(15.0%) | 218(15.4%) | 14(11.2%) | |
| Macrovascular Invasion, (%) | 158(10.2%) | 145(10.2%) | 13(10.4%) | 0.879 |
| ASA | 228(14.8%) | 177(12.5%) | 51(40.8%) | <0.001 |
| Charlson index,median (IQR | 1(0–1) | 1(0–1) | 1(0–1) | 0.476 |
| Hypertension, (%) | 277(18.0%) | 254(17.9%) | 23(18.4%) | 0.903 |
| Pulmonary disease, (%) | 47(3.0%) | 39(2.8%) | 8(6.4%) | 0.049 |
| Cardiovascular disease, (%) | 42(2.7%) | 40(2.8%) | 2(1.6%) | 0.605 |
| Diabetes mellitus, (%) | 117(7.6%) | 105(7.4%) | 12(9.6%) | 0.377 |
| Portal hypertension, (%) | 428(27.7%) | 345(24.3%) | 83(66.4%) | <0.001 |
*HBsAg: hepatitis B surface antigen; HBeAg: hepatitis B e antigen; BMI:Body mass index.HBV-DNA(+) indicated hepatitis B DNA>2000 U/ml; IQR: interquartile range; ALT, alanine aminotransferase; AST, aspartate aminotransferase. ASA: American Society of Anesthesiologists category. Pulmonary disease indicated chronic obstructive pulmonary disease, asthma, chronic bronchitis and tuberculosis. Cardiovascular disease included coronary heart disease, previous coronary revascularization, cerebral arterial occlusive disease, and/or peripheral vascular occlusive disease. Tumor size indicated the sum of all the tumors diameter.
Intraoperative Parameters and Postoperative Outcomes.
| Intraoperative Parameters | All patients (n = 1543) | No Complications–Grade II(n = 1418) | Grades III–V (n = 125) | P value |
| Major resection, (%) | 574 (37.2%) | 489(34.5%) | 85(68%) | <0.001 |
| Extrahepatic procedures,(%) | 278 (18%) | 236(16.6%) | 42(33.6%) | <0.001 |
| Diaphragm resection | 28(1.8%) | 24(1.7%) | 4(3.2%) | 0.389 |
| Vascular procedures | 61(4.0%) | 47(3.3%) | 14(11.2%) | <0.001 |
| Splenectomy | 16(1.0%) | 11(0.8%) | 5(4.0%) | 0.003 |
| Bowel resection | 18(1.2%) | 14(1.0%) | 4(3.2%) | 0.076 |
| Biliary tract procedures | 39(2.5%) | 32(2.3%) | 7(5.6%) | 0.047 |
| Inflow occlusion, (%) | 642(41.6%) | 592(41.7%) | 50(40.0%) | 0.389 |
| Hooking with ligation,(%) | 538 (34.9%) | 501 (35.3%) | 37 (29.6%) | 0.205 |
| Ultrasonic dissector,(%) | 1005(65.1%) | 917(64.7%) | 88(70.4%) | 0.205 |
| Blood loss (ml), median (IQR | 400(200–600) | 400(200–530) | 500(300–800) | <0.001 |
| Blood transfusion, (%) | 288 (19.3%) | 244(17.2%) | 44 (35.2%) | <0.001 |
| ICU | 0(0–1) | 0(0–1) | 1(0–2) | <0.001 |
| Hospital stays(days), median (IQR | 12(10–15) | 12(10–14) | 19(13–24) | <0.001 |
*ICU: Intensive Care Unit. IQR: interquartile range. Vascular procedures included resection tumor thrombus of portal vein, hepatic vein and procedures including vena veins.
Postoperative Complications Grade.
| Postoperative Complication Grade, Number (%) | All patients (n = 1543) | No Complications–Grade II(n = 1418) | Grades III–V (n = 125) |
| No complications | 1079(69.9%) | 1079(76.1%) | 0 |
| Grade I | 146(9.5%) | 146(10.3%) | 0 |
| Grade II | 193(12.5%) | 193(13.6%) | 0 |
| Grade IIIa | 58(3.8%) | 0 | 58(46.4%) |
| Grade IIIb | 13(0.8%) | 0 | 13(10.4%) |
| Grade IV | 31(2%) | 0 | 31(24.8%) |
| Grade V | 23(1.5%) | 0 | 23(18.4%) |
Development of Predictor Score Based on Logistic Regression Analysis.
| Predictor | Categories | Regression Coefficient β | Odds Ratio (β) | p value | Risk Score |
| Resection Extent | Major | 3.156 | 23.473 | <0.001 | 4 |
| Minor | Reference | 1 | 0 | ||
| Portal hypertension | Yes | 3.021 | 20.502 | <0.001 | 3 |
| No | Reference | 1 | 0 | ||
| ASA | III and IV | 2.079 | 7.999 | <0.001 | 2 |
| I and II | Reference | 1 | 0 | ||
| Extrahepatic procedure | Yes | 1.254 | 3.503 | <0.001 | 1 |
| No | Reference | 1 | 0 |
Figure 1Receiver operator characteristic curve analysis of preoperative risk factors to predict liver resection postoperative severe complication in development group (area under the curve = 0.898,P<0.0001).
Figure 2Receiver operator characteristic curve analysis of preoperative risk factors to predict liver resection postoperative severe complication in validation group (area under the curve = 0.798,P<0.0001).